Vivimed Labs rose 1.09% to Rs 372 at 13:52 IST on BSE after consolidated net profit rose 45.52% to Rs 23.88 crore on 7.46% rise in net sales to Rs 337.03 crore in Q2 September 2015 over Q2 September 2014.
The result was announced during trading hours today, 13 November 2015.
Meanwhile, the BSE Sensex was down 258.75 points, or 1%, to 25,608.20.
On BSE, so far 27,000 shares were traded in the counter, compared with an average volume of 61,412 shares in the past one quarter.
The stock hit a high of Rs 381.70 and a low of Rs 361 so far during the day. The stock hit a 52-week high of Rs 435.40 on 1 December 2014. The stock hit a 52-week low of Rs 175 on 24 June 2015.
Also Read
The stock had outperformed the market over the past one month till 11 November 2015, rising 9.20% compared with 4.48% decline in the Sensex. The scrip had also outperformed the market in past one quarter, rising 38.09% as against Sensex's 7.17% decline.
The small-cap company has an equity capital of Rs 16.20 crore. Face value per share is Rs 10.
Vivimed Labs is a leading manufacturer and exporter of specialty chemicals mainly used in the personal-care and pharmaceutical industries.
Powered by Capital Market - Live News
